ClinicalTrials.gg
CompletedNCT00888537Updated Mar 21, 2016

Wiser Choices in Acute Myocardial Infarction

An interventional study of AMI Choice Decision Aid and Usual Care in Acute Myocardial Infarction, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2016-03-21.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
107
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Patients who are hospitalized because of a heart attack are prescribed a number of medicines to help the heart heal. The investigators will examine different ways in which clinicians share information about those treatment options with patients and the impact that this can have on patients' choices and health.

02

Conditions studied

  • Acute Myocardial Infarction

Keywords

  • Decision aid
  • Heart attack
  • myocardial infarction
03

In context

Myocardial Infarction

2,779 studies on the registry are indexed under Myocardial Infarction; 417 are open to participants now.

This study's enrollment of 107 is below the median of 148 across 1,613 interventional studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,263 studies on the registry; 670 are open to participants now.

Of its 450 completed or terminated interventional studies of FDA-regulated products, 318 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 18 and 90
  • Hospitalized at Saint Marys Hospital
  • A primary diagnosis of AMI,
  • Have heart rate, blood pressure, troponin and creatinine measurements,
  • There is an intention to offer treatment medications
  • Are able and willing to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Have not had a myocardial infarction
  • Have significant cognitive, visual impairment,
  • Non-English speaker
  • Have a Do Not Intubate/Do Not Resuscitate (DNI/DNR) status
  • Will be discharged to a nursing home
  • AMI is not the presumptive diagnosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
107 participants (actual)

Study arms

  • Experimental
    Decision Aid

    Patients in this arm will discuss medications to help the heart heal after a heart attack with the clinician and the help of the acute myocardial infarction (AMI) Choice Decision Aid.

    Other: AMI Choice Decision Aid

  • Active comparator
    Usual Care

    Patients and clinicians in this arm will discuss medications to help the heart heal after a heart attack in their usual manner.

    Other: Usual Care

Interventions

  • OtherAMI Choice Decision Aid

    The decision aid describes the risk of dying in the first six months following a heart attack without and with taking a bundle of medications to help the heart heal.

  • OtherUsual Care

    Patients and clinicians in this arm will discuss medications to help the heart heal after a heart attack in their usual manner.

06

What researchers measure

Primary outcomes

  1. Increases adherence to cardiac medications with proven benefits

    Time frame: 6 months

  2. Reduces patients' decisional conflict (increase patient decisional quality)

    Time frame: During hospital stay

  3. Decreases rehospitalization rates and death

    Time frame: 5 weeks and 6 months

  4. Increase patient knowledge of medication to help the heart heal

    Time frame: During hospital stay

07

Study locations

1 site
  • Saint Marys Hospital, Mayo Clinic
    Rochester, Minnesota 55905, United States
08

References and documents

Publications

  • Branda ME, Kunneman M, Meza-Contreras AI, Shah ND, Hess EP, LeBlanc A, Linderbaum JA, Nelson DM, Mc Donah MR, Sanvick C, Van Houten HK, Coylewright M, Dick SR, Ting HH, Montori VM. Shared Decision-Making for Patients Hospitalized with Acute Myocardial Infarction: A Randomized Trial. Patient Prefer Adherence. 2022 Jun 1;16:1395-1404. doi: 10.2147/PPA.S363528. eCollection 2022. PubMed 35673524 ↗
  • Wyatt KD, Branda ME, Inselman JW, Ting HH, Hess EP, Montori VM, LeBlanc A. Genders of patients and clinicians and their effect on shared decision making: a participant-level meta-analysis. BMC Med Inform Decis Mak. 2014 Sep 2;14:81. doi: 10.1186/1472-6947-14-81. PubMed 25179289 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00888537
Lead sponsor
Mayo Clinic
Responsible party
Nilay D. Shah (MD, Mayo Clinic) — Principal investigator
First posted
Apr 27, 2009
Start date
Mar 2009
Primary completion
Jun 2011
Completion
Jun 2011
Last update
Mar 21, 2016

Study contacts

Henry Ting, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion